Chronic fatigue syndrome and/or fibromyalgia as a variation of antiphospholipid antibody syndrome: an explanatory model and approach to laboratory diagnosis

Blood Coagul Fibrinolysis. 1999 Oct;10(7):435-8. doi: 10.1097/00001721-199910000-00006.

Abstract

Chronic Fatigue and/or Fibromyalgia have long been diseases without definition. An explanatory model of coagulation activation has been demonstrated through use of the ISAC panel of five tests, including, Fibrinogen, Prothrombin Fragment 1+2, Thrombin/ AntiThrombin Complexes, Soluble Fibrin Monomer, and Platelet Activation by flow cytometry. These tests show low level coagulation activation from immunoglobulins (Igs) as demonstrated by Anti-B2GPI antibodies, which allows classification of these diseases as a type of antiphospholipid antibody syndrome. The ISAC panel allows testing for diagnosis as well as monitoring for anticoagulation protocols in these patients.

MeSH terms

  • Antiphospholipid Syndrome / classification
  • Antiphospholipid Syndrome / diagnosis*
  • Clinical Laboratory Techniques*
  • Diagnosis, Differential
  • Fatigue Syndrome, Chronic / diagnosis*
  • Fibromyalgia / diagnosis*
  • Humans